At a glance
- Originator Nonindustrial source
- Class Antibacterials; Macrolides
- Mechanism of Action Protein 50S ribosomal subunit inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Bacterial infections
Most Recent Events
- 14 Apr 1997 No-Development-Reported for Bacterial infections in Japan (Unknown route)
- 18 May 1995 New profile
- 18 May 1995 Preclinical development for Bacterial infections in Japan (Unknown route)